ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Retail Trade

cocokara fine, Inc.

Business Summary

cocokara fine, Inc. engages in the planning and management of its group companies that are involved in drugstore chain operations. It operates through the following segments: Drug Store and Pharmacy Business, Nursing Care Business, and Others. The Drug Store and Pharmacy Business segment deals with the retail distribution of pharmaceutical products, cosmetics, and household items. The Nursing Care Business segment operates nursing care facilities and offers home-care services. The Others segment covers wholesale, e-commerce and international businesses. The company was founded on April 1, 2008 and is headquartered in Yokohama, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue403,875M3,714.62M
Gross Profit108,098M994.22M
Operating income13,338M122.67M
Income before tax12,971M119.30M
Net income8,270M76.06M
EBITDA17,863M164.29M
Diluted EPS344.053.16
Dividends Per Share920.84
Total Assets208,298M1,929.48M
Total liabilities68,642M635.83M
Total equity139,653M1,293.62M
Operating cash flow12,919M118.82M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 373,275M 377,203M 390,963M 400,559M 403,875M
Gross Profit 92,774M 93,564M 101,205M 104,914M 108,098M
Operating income 11,119M 10,140M 13,665M 12,905M 13,338M
Income before tax 11,705M 11,339M 14,638M 13,795M 12,971M
Net income 6,927M 7,037M 9,067M 9,158M 8,270M
EBITDA 15,022M 14,162M 17,641M 16,870M 17,863M
Diluted EPS 279.32 286.79 376.38 381.24 344.05
Dividends Per Share 70 70 73 76 92
Total Assets 142,404M 146,963M 158,177M 172,727M 208,298M
Total liabilities 64,449M 63,723M 70,365M 77,644M 68,642M
Total equity 77,955M 83,237M 87,810M 95,081M 139,653M
Operating cash flow 17,809M 9,381M 17,117M 9,388M 12,919M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 3,108.44M 3,483.34M 3,527.51M 3,612.06M 3,714.62M
Gross Profit 772.57M 864.03M 913.13M 946.06M 994.22M
Operating income 92.59M 93.63M 123.29M 116.37M 122.67M
Income before tax 97.47M 104.71M 132.07M 124.39M 119.30M
Net income 57.68M 64.98M 81.80M 82.58M 76.06M
EBITDA 125.09M 130.78M 159.16M 152.12M 164.29M
Diluted EPS 2.32 2.64 3.39 3.43 3.16
Dividends Per Share 0.58 0.64 0.65 0.68 0.84
Total Assets 1,266.99M 1,318.88M 1,487.32M 1,560.52M 1,929.48M
Total liabilities 573.41M 571.86M 661.63M 701.48M 635.83M
Total equity 693.58M 746.98M 825.66M 859.02M 1,293.62M
Operating cash flow 148.30M 86.63M 154.44M 84.65M 118.82M

Valuation Measures

Mar 2020
PER16.30
ROA4.34%
ROE7.04%
Operating margin3.30%
Profit margin2.04%

Key executives

  • President & Representative Director: Atsushi Tsukamoto
  • Executive Officer & Manager-Information Technology: Yasuyuki Oike
  • Senior Manager-Compliance & Manager-Legal Affairs: Masafumi Morita
  • Director, VP, GM-Administration & Manager-Strategy: Tsuyoshi Yamamoto
  • Executive Officer & Manager-Internal Audit Office: Ryoichi Wachi

Shareholders

  • Matsumotokiyoshi Holdings Co., Ltd. (19.1%)
  • Seishin Kagaku Kai (5.3%)
  • cocokara fine, Inc. (4.3%)
  • Pictet Asset Management Ltd. (3.2%)
  • Cocokara Fine Holdings Employee Stock Ownership Plan (2.8%)
  • SEGAMI FAMILY (2.6%)
  • Nomura Asset Management Co., Ltd. (2.3%)
  • Daiichi Sankyo Co., Ltd. (1.9%)
  • SAITO MAYUMI (1.8%)
  • Baillie Gifford & Co. (1.8%)

Contact Details

Related Companies

  • Yakuho Shoji YK
  • Flight YK
  • Koishikawa Pharmacy KK
  • K S YK
  • Cocokara Fine Employee Incentive Plan
  • Senior Cosmos Co., Ltd.
  • Toho Chozai YK
  • cocokarafine soleil Co. Ltd.
  • Yamamoto Service KK
  • Shanghai Cocokara Fine, Inc.
  • Cocokara Fine Next Co., Ltd.
  • cocokarafine associe, Inc.
  • cocokara fine OEC, Inc.
  • Cocokara fine Healthcare, Inc.
  • I System KK (Yamaguchi)
  • Kojido Corp.
  • Kusuri No Ebina YK
  • Finecare, Inc.
  • Kodama Co., Ltd. (Niigata)
  • Reha Works YK
  • Medical Index YK
  • Aianju KK
  • SO Pharmaceutical Corp.
  • Cocokara Fine Holdings Employee Stock Ownership Plan
  • Kotobuki YK
  • Koshi Yakkyoku YK
  • Iwasaki Kokendo KK
  • Suzuran Pharmacy KK
  • Takara Care Co. Ltd.
  • Segami Medics Co. Ltd.

Competitors

  • Welcia Holdings Co., Ltd.
  • Create SD Holdings Co., Ltd.
  • TSURUHA Holdings, Inc.
  • Pharmarise Holdings Corp.
  • Medical System Network Co., Ltd.
  • COSMOS Pharmaceutical Corporation
  • KUSURI NO AOKI HOLDINGS CO.,LTD.
  • Sugi Holdings Co., Ltd.
  • Sundrug Co., Ltd.
  • Matsumotokiyoshi Holdings Co., Ltd.
  • Nihon Chouzai Co., Ltd.
  • Ain Holdings Inc.
  • Qol Holdings Co., Ltd.
Last Updated on 28 Oct, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more